Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2007-11-30 Share Issue/Capital Cha…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Share Issue/Capital Change 2007
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated November 30, 2007, detailing the conversion of 10,000 stock options into shares, which resulted in an increase in the total number of shares and the share capital. This action directly relates to changes in the company's capital structure and the issuance of new shares based on an existing option program. This aligns best with the 'Share Issue/Capital Change' definition (SHA), as it describes an increase in the number of shares outstanding due to option exercise, which is a form of capital change/share issuance event.
2007-11-30 Swedish
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a 'Press release' dated October 30, 2007, announcing that Vitrolife has received sales approval from the Australian Medical Products Agency (TGA) for its fertility media. This is a specific operational update concerning regulatory clearance and market access, not a standard financial report (like 10-K, IR, ER) or a general shareholder communication (like AGM, DEF 14A). It does not fit neatly into the primary financial reporting categories. Since it is a specific announcement regarding regulatory/operational status that doesn't match other specific codes (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory announcements.
2007-10-30 English
Regulatory Filings 2007
Regulatory Filings Classification · 95% confidence The document is a press release dated October 30, 2007, announcing that Vitrolife has received sales approval (registration approval) from the Australian regulatory body (TGA) for its fertility media. It also mentions the issuance of a 'Conformity Assessment Certificate' for their quality system. This type of announcement, detailing regulatory milestones, market access achievements, or specific operational updates outside of standard financial reporting (10-K, IR, ER), fits best under a general regulatory announcement or a specific update category. Since it is not a financial report (10-K, IR, ER), a management change (MANG), a director trade (DIRS), or a dividend notice (DIV), it is most appropriately classified as a general Regulatory Filing (RNS) or potentially a Legal/Regulatory update (LTR), although it is positive news. Given the context of a press release announcing a regulatory approval/certification, RNS (Regulatory Filings - general regulatory announcements and fallback) is the most suitable general category for non-standard, non-financial disclosures.
2007-10-30 Swedish
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Vitrolife AB covering the period January–September 2007. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, segments, and outlook. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2007
2007-10-25 Swedish
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim report' for the period January–September 2007 for Vitrolife AB. It contains detailed financial statements, including net sales, gross income, operating income, cash flow, and balance sheet data, as well as management's analysis of business performance, product segments, and organizational updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2007
2007-10-25 English
Report Publication Announcement 2007
Report Publication Announcement Classification · 99% confidence The document is explicitly titled "Conference call interim report" and serves as an invitation to a conference call to discuss the interim report for the period January-September 2007. It provides the time, date, dial-in details, and names of participants for the call where the results will be presented. This structure—an announcement inviting participation in a discussion about financial results—is characteristic of a Call Transcript (CT) announcement or, more accurately in this context, the material *leading up to* a call that would generate a transcript. However, since the document itself is an invitation/announcement about the presentation of an interim report, and not the transcript itself, we must look for the best fit. It is not the full Interim Report (IR) or Earnings Release (ER), but an announcement related to the discussion of those results. Given the options, the document is an invitation to a conference call, which strongly aligns with the purpose of a Call Transcript (CT) document, even if it's the pre-call announcement. If the document contained the Q&A, it would definitively be CT. Since it is the invitation to the call where the interim report is discussed, CT is the most relevant category related to the event described. Alternatively, it could be seen as a Report Publication Announcement (RPA) because it announces the release of the press release for the interim report, but the primary focus is the conference call event itself.
2007-10-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.